Contamination Control Strategy (CCS): Integrating Sterilization, Environmental Monitoring, and Aseptic Operations

Contamination Control Strategy (CCS) has become a central expectation under EU GMP Annex 1, requiring organizations to demonstrate how contamination risks are understood, controlled, monitored, and continuously managed across sterile manufacturing operations. While many facilities already maintain environmental monitoring programs, sterilization controls, aseptic procedures, investigations, and quality systems, Annex 1 increasingly expects these activities to function as part of an integrated contamination control approach rather than as separate compliance programs. Questions often emerge around how individual controls connect, how contamination risks are evaluated across the manufacturing lifecycle, and whether existing systems collectively support sterility assurance.

This session examines CCS from an operational perspective, focusing on how sterilization activities, environmental monitoring programs, aseptic operations, investigations, and risk management practices function together within modern sterile manufacturing environments. Practical examples will be used to explore how contamination control decisions are supported, how weaknesses develop across interconnected systems, and how organizations can build more effective and defensible contamination control programs under Annex 1 expectations.

| WHY YOU SHOULD ATTEND

A facility may have acceptable environmental monitoring results, validated sterilization processes, trained operators, approved procedures, and completed investigations. Yet observations continue to occur because regulators increasingly review contamination control as a connected system rather than a series of individual programs. Under Annex 1, evidence supporting sterility assurance is expected to extend beyond individual controls and demonstrate how risks are understood and managed across the broader operation.

CCS places increasing emphasis on understanding the relationships between monitoring data, sterilization activities, aseptic practices, facility controls, investigations, and operational behavior. Decisions made in one area can influence risk in another long before a quality event occurs. This session focuses on how those relationships are evaluated in practice and how organizations build confidence that contamination risks remain controlled throughout the sterile manufacturing lifecycle.

| AREAS COVERED

• CCS Expectations Under EU GMP Annex 1
• How Sterilization Decisions Influence Broader Contamination Control Outcomes
• Environmental Monitoring Signals That Deserve Attention Before Excursions Occur
• Routine Aseptic Practices That Gradually Increase Contamination Risk
• Connecting Environmental Monitoring, Investigations, and Sterility Assurance Activities
• Intervention Practices, Operator Behavior, and Their Impact on CCS Effectiveness
• Evidence Inspectors Expect When Assessing CCS Under Annex 1
• Building a CCS That Supports Operational Decision-Making and Sterility Assurance

| WHO SHOULD ATTEND

• Quality Assurance (QA)
• Sterility Assurance Professionals
• Microbiology and Environmental Monitoring Personnel
• Sterile Manufacturing and Operations Teams
• Validation and Qualification Professionals
• Quality Control (QC)
• Engineering and Technical Services Personnel
• Regulatory and Compliance Professionals

Course Director: Meredith Crabtree

Meredith Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Cleaning Validation, Analytical Methods and Change Control. She also performs regulatory assessments and Quality trainings.